Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants
- PMID: 8334997
- PMCID: PMC413531
- DOI: 10.1002/j.1460-2075.1993.tb05942.x
Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants
Abstract
Fusion of the hormone binding domain (HBD) of steroid receptors to transcription factors renders them hormone-dependent. We show here that an SH3-deleted, oncogenic variant of the Abl tyrosine kinase becomes hormone-dependent for transformation by fusion to the estrogen receptor (ER) HBD, extending the phenomenon to tyrosine kinases. Surprisingly, fusion of the HBD to the normal, non-transforming c-Abl (IV) protein activated transforming activity in a hormone-dependent fashion. In the presence of hormone, the c-Abl:ER fusion protein was transforming, cytoplasmic and tyrosine phosphorylated, whereas it was non-transforming, nuclear and hypophosphorylated without hormone. We have examined the kinetics of activation of the c-Abl:ER protein and found that protein synthesis is required both for kinase activation and for redistribution of the c-Abl:ER protein from the nucleus to the cytoplasm. We suggest that the activation of c-Abl could be due to HBD-mediated dimerization and/or to the ability to overexpress conditionally the normally toxic c-Abl protein. This novel approach may be applicable to a wide variety of proteins, particularly when activating mutations or physiological inducers are unknown or when the protein is toxic to cells.
Similar articles
-
Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization.J Biol Chem. 2001 Jun 29;276(26):24372-9. doi: 10.1074/jbc.M100786200. Epub 2001 Apr 24. J Biol Chem. 2001. PMID: 11320088
-
Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.Mol Cell Biol. 1994 May;14(5):2883-94. doi: 10.1128/mcb.14.5.2883-2894.1994. Mol Cell Biol. 1994. PMID: 8164650 Free PMC article.
-
Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.Genes Dev. 1994 Apr 1;8(7):783-95. doi: 10.1101/gad.8.7.783. Genes Dev. 1994. PMID: 7926767
-
Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells.Biol Cell. 2008 Nov;100(11):617-31. doi: 10.1042/BC20080020. Biol Cell. 2008. PMID: 18851712 Review.
-
Regulation of the c-Abl and Bcr-Abl tyrosine kinases.Nat Rev Mol Cell Biol. 2004 Jan;5(1):33-44. doi: 10.1038/nrm1280. Nat Rev Mol Cell Biol. 2004. PMID: 14708008 Review.
Cited by
-
Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins.Nucleic Acids Res. 1995 May 25;23(10):1647-56. doi: 10.1093/nar/23.10.1647. Nucleic Acids Res. 1995. PMID: 7540284 Free PMC article. Review. No abstract available.
-
Regulation of Cre recombinase activity by the synthetic steroid RU 486.Nucleic Acids Res. 1996 Apr 15;24(8):1404-11. doi: 10.1093/nar/24.8.1404. Nucleic Acids Res. 1996. PMID: 8628671 Free PMC article.
-
A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells.BMC Immunol. 2001;2:4. doi: 10.1186/1471-2172-2-4. Epub 2001 Jun 8. BMC Immunol. 2001. PMID: 11410123 Free PMC article.
-
Genetic Engineering of Zebrafish in Cancer Research.Cancers (Basel). 2020 Aug 4;12(8):2168. doi: 10.3390/cancers12082168. Cancers (Basel). 2020. PMID: 32759814 Free PMC article. Review.
-
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.Nucleic Acids Res. 1995 May 25;23(10):1686-90. doi: 10.1093/nar/23.10.1686. Nucleic Acids Res. 1995. PMID: 7784172 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous